Funding for this research was provided by:
japan agency for medical research and development (21bk0104124h0001)
Japan Society for the Promotion of Science (JP20K08592)
Received: 7 May 2021
Accepted: 8 August 2021
First Online: 23 August 2021
: The Medical Ethics Committee of Hiroshima Graduate School of Biomedical Science permitted collection of the bone marrow (Permit number: E-1089). All experimental procedures were approved by the Institutional Animal Care and Use Committee of Hiroshima University (Permit number: A16-83).
: Not applicable.
: The Department of Stem Cell Biology and Medicine, Graduate School of Biomedical & Health Sciences, Hiroshima University is a collaborative research laboratory funded by TWOCELLS Company, Limited. Dr. Maeda is the Vice manager of R&D Division, Head Office of Research and Development of TWOCELLS Company, Limited. Except for the abovementioned disclosures, all other authors have declared that no conflict of interest exists.